Quick answer
Without insurance, the FDA-approved semaglutide products, Wegovy and Ozempic, have carried list prices that nationally run on the order of roughly $1,000 to $1,400 per month, though manufacturer savings programs, self-pay arrangements, and direct purchase options can lower that substantially for eligible people. What you actually pay depends heavily on your insurance status, savings-program eligibility, pharmacy, and which product you need. Prices change and vary by source, so treat any figure as a national reference point, not a quote. Confirm current pricing directly with the clinic and your pharmacy. These are prescription medications requiring physician supervision.
What Is the List Price of Semaglutide Without Insurance?
Nationally, the FDA-approved semaglutide products have carried monthly list prices in the rough range of $1,000 to $1,400 without insurance, depending on the product and dose. Ozempic (the diabetes brand) and Wegovy (the weight-management brand) are priced separately. These are list prices, the starting point before any discounts, and few people pay the full list price once savings programs or coverage are factored in. Because manufacturers periodically adjust prices and introduce direct self-pay options, the real number moves.
Treat these figures as a national orientation, not a personal quote. The price you face depends on your insurance, eligibility for savings programs, and pharmacy. To get an accurate number, you need to run your specific situation, which a clinic or pharmacy can help with. Do not assume the list price is what you will pay or what any particular clinic charges.
Why Does Semaglutide Cost So Much Without Insurance?
The high list price reflects that these are newer branded biologic medications under patent, with significant demand and limited direct competition at the brand level. Without insurance to absorb part of the cost, the patient sees more of that list price directly. This is also why coverage status is the single biggest driver of what people actually pay: a covered prescription can cost a fraction of the list price, while an uncovered one can approach it.
Weight-management use complicates this further, because many insurance plans cover GLP-1s for diabetes more readily than for weight management, so two people on the same drug can pay very differently based on diagnosis and plan. This coverage gap is why so many people end up exploring savings programs, self-pay options, or compounded alternatives.
How Can You Lower the Cost of Semaglutide?
The main levers are insurance coverage, manufacturer savings programs, manufacturer direct self-pay offerings, and confirming your diagnosis and plan rules with a prescriber. Manufacturers have offered savings cards and direct-purchase programs that can meaningfully reduce monthly cost for eligible people, though eligibility often depends on insurance status. A prescriber and pharmacy can help you check which of these you qualify for and whether prior authorization can unlock coverage.
Some people consider compounded semaglutide because it is usually cheaper, but it is not an FDA-approved product and carries different oversight, so cost should not be the only factor. We cover that fully in our guide on compounded vs brand-name semaglutide. The honest approach is to weigh price against safety and supervision together.
What Does Supervised Weight-Loss Treatment Actually Cost?
The medication is only one part of the total cost of supervised treatment. A proper weight-loss program also includes the medical evaluation, lab monitoring, and follow-up visits that make GLP-1 therapy safe, and those have their own costs separate from the drug. When comparing options, it helps to look at the all-in cost of supervised care, not just the price of a vial or pen, because cheap medication without supervision is not a bargain if it skips monitoring.
Pricing for the clinical program varies by practice and is not something to assume from a national drug price. Ascend's medical weight loss program can walk through what is included and what to expect, and your insurance and savings-program eligibility for the medication itself.
Care at Ascend: Learn more about Weight Loss at Ascend Mind and Body, or book an appointment.
Frequently asked questions
How much is semaglutide per month without insurance?
Nationally, brand semaglutide list prices have run roughly $1,000 to $1,400 per month without coverage, but most people pay less through savings programs, self-pay offers, or coverage. The real number depends on your insurance, eligibility, pharmacy, and product. Confirm current pricing with the clinic and pharmacy rather than relying on a list price.
Is compounded semaglutide cheaper than brand?
Usually, yes, but it is not an FDA-approved product and is not evaluated for safety, effectiveness, and quality the way brand products are. A lower price does not make it equivalent to Ozempic or Wegovy. Weigh cost against oversight and the FDA's stated concerns, and make the decision with a prescriber.
Does insurance in Florida cover semaglutide for weight loss?
It varies by plan. Many Florida insurance plans cover GLP-1s for type 2 diabetes more readily than for weight management, and prior authorization is common. Coverage depends on your specific policy and diagnosis, so check directly with your plan. A prescriber can help with prior authorization where appropriate.
Can I get semaglutide by telehealth in Florida, and does that change the cost?
Often you can be evaluated and prescribed by telehealth in Florida when appropriate, and the visit format does not change the medication's price, which is set by the manufacturer, pharmacy, and your coverage. Telehealth may affect the cost of the clinical visits themselves, which varies by practice. Confirm both the medication and program costs with the clinic.
Medically reviewed by
Dr. Jason Saylor, DO
This article is for general educational purposes only and is not medical advice. It does not create a provider-patient relationship. Talk with a qualified Florida-licensed clinician about your individual situation.
Sources
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). Prescription Medications to Treat Overweight and Obesity. niddk.nih.gov.
- U.S. Food and Drug Administration. Wegovy (semaglutide) injection prescribing information. accessdata.fda.gov.
- U.S. Food and Drug Administration. Medications Containing Semaglutide Marketed for Type 2 Diabetes or Weight Loss. fda.gov.